Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GPR30: a novel indicator of poor survival for endometrial carcinoma.
Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER. Smith HO, et al. Among authors: qualls cr. Am J Obstet Gynecol. 2007 Apr;196(4):386.e1-9; discussion 386.e9-11. doi: 10.1016/j.ajog.2007.01.004. Am J Obstet Gynecol. 2007. PMID: 17403429
GPR30 predicts poor survival for ovarian cancer.
Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. Smith HO, et al. Among authors: qualls cr. Gynecol Oncol. 2009 Sep;114(3):465-71. doi: 10.1016/j.ygyno.2009.05.015. Epub 2009 Jun 6. Gynecol Oncol. 2009. PMID: 19501895 Free PMC article.
Incidence and survival rates for female malignant germ cell tumors.
Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, Qualls CR. Smith HO, et al. Among authors: qualls cr. Obstet Gynecol. 2006 May;107(5):1075-85. doi: 10.1097/01.AOG.0000216004.22588.ce. Obstet Gynecol. 2006. PMID: 16648414
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
Arias-Pulido H, Cimino-Mathews AM, Chaher N, Qualls CR, Joste N, Colpaert C, Marotti JD, Chamberlin MD, Foisey MG, Prossnitz ER, Emens LA, Fiering S. Arias-Pulido H, et al. Among authors: qualls cr. Breast Cancer Res Treat. 2021 Dec;190(3):477-489. doi: 10.1007/s10549-021-06391-5. Epub 2021 Sep 20. Breast Cancer Res Treat. 2021. PMID: 34542773 Free PMC article.
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H, Cimino-Mathews A, Chaher N, Qualls C, Joste N, Colpaert C, Marotti JD, Foisey M, Prossnitz ER, Emens LA, Fiering S. Arias-Pulido H, et al. Breast Cancer Res Treat. 2018 Sep;171(2):273-282. doi: 10.1007/s10549-018-4834-7. Epub 2018 Jun 1. Breast Cancer Res Treat. 2018. PMID: 29858752 Free PMC article.
Changing trends in gestational trophoblastic disease.
Smith HO, Wiggins C, Verschraegen CF, Cole LW, Greene HM, Muller CY, Qualls CR. Smith HO, et al. Among authors: qualls cr. J Reprod Med. 2006 Oct;51(10):777-84. J Reprod Med. 2006. PMID: 17086806
303 results